http://www.onemedplace.com/blog/wp-content/uploads/2009/07/lungs-small.jpg

The drug candidate IL13-PE has the potential to be the first effective therapy for idiopathic pulmonary fibrosis (IPF), which kills an estimated 40,000 people in the United States each year.